Atezolizumab as first-line (1L) therapy for advanced non-small cell lung cancer (NSCLC) in PD-L1-selected patients: Efficacy data from the BIRCH trial Meeting Abstract
| Authors: | Peters, S.; Costa, E. C.; Garassino, M. C.; Christoph, D.; Kurata, T.; Chaft, J.; Johnson, M. L.; Mocci, S.; Gettinger, S. N.; Felip, E. |
| Abstract Title: | Atezolizumab as first-line (1L) therapy for advanced non-small cell lung cancer (NSCLC) in PD-L1-selected patients: Efficacy data from the BIRCH trial |
| Meeting Title: | 7th European Lung Cancer Conference (ELCC 2017) |
| Journal Title: | Annals of Oncology |
| Volume: | 28 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2017 May 5-8 |
| Meeting Location: | Geneva, Switzerland |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2017-04-01 |
| Start Page: | mdx091.004 |
| Language: | English |
| ACCESSION: | WOS:000405512800072 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdx091.004 |
| Notes: | Meeting Abstract: 840 -- Appears on pages 29-30 of the abstract book -- Source: Wos |
